Subtopic Deep Dive

Homologous Recombination Repair
Research Guide

What is Homologous Recombination Repair?

Homologous recombination repair (HRR) is an error-free DNA repair pathway that uses a sister chromatid as a template to accurately repair double-strand breaks via RAD51-mediated strand invasion.

HRR operates primarily in S/G2 phases when sister chromatids are available. Key players include BRCA1/2 proteins and Fanconi anemia pathway components. Over 10,000 papers explore HRR mechanisms and therapeutic targeting, with foundational works like Li and Heyer (2008) detailing its role in DNA damage tolerance.

15
Curated Papers
3
Key Challenges

Why It Matters

HRR defects in BRCA-mutated cancers create synthetic lethality with PARP inhibitors like olaparib, enabling precision oncology. Fong et al. (2009) demonstrated olaparib's antitumor activity in BRCA mutation carriers (3582 citations). Golan et al. (2019) showed prolonged progression-free survival in BRCA-mutated pancreatic cancer (2107 citations). Tutt et al. (2021) confirmed adjuvant olaparib benefits in BRCA-mutated breast cancer (1531 citations), transforming treatment standards.

Key Research Challenges

Pathway Choice Regulation

Cells must select HRR over error-prone non-homologous end joining for double-strand breaks. Shrivastav et al. (2007) outline factors influencing this choice (1304 citations). Dysregulation leads to genomic instability in cancers.

BRCA Deficiency Exploitation

Therapeutic targeting of HRR-deficient tumors faces resistance mechanisms. Bukowski et al. (2020) detail multidrug resistance in chemotherapy contexts (1646 citations). Huang and Zhou (2020) explore DDR pathway sensitization (1065 citations).

DDR Kinase Coordination

ATM and ATR kinases sense damage and regulate HRR timing. Abraham (2001) describes checkpoint signaling (1956 citations). Maréchal and Zou (2013) detail damage sensing (1446 citations).

Essential Papers

1.

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from <i>BRCA</i> Mutation Carriers

Peter C.C. Fong, David S. Boss, Timothy A. Yap et al. · 2009 · New England Journal of Medicine · 3.6K citations

Olaparib has few of the adverse effects of conventional chemotherapy, inhibits PARP, and has antitumor activity in cancer associated with the BRCA1 or BRCA2 mutation. (ClinicalTrials.gov number, NC...

2.

Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer

Talia Golan, Pascal Hammel, Michele Reni et al. · 2019 · New England Journal of Medicine · 2.1K citations

Among patients with a germline <i>BRCA</i> mutation and metastatic pancreatic cancer, progression-free survival was longer with maintenance olaparib than with placebo. (Funded by AstraZeneca and ot...

3.

Cell cycle checkpoint signaling through the ATM and ATR kinases

Robert T. Abraham · 2001 · Genes & Development · 2.0K citations

The genomes of eukaryotic cells are under continuous assault by environmental agents (e.g., UV light and reactive chemicals) as well as the byproducts of normal intracellular metabolism (e.g., reac...

4.

Mechanisms of Multidrug Resistance in Cancer Chemotherapy

Karol Bukowski, Mateusz Kciuk, Renata Kontek · 2020 · International Journal of Molecular Sciences · 1.6K citations

Cancer is one of the main causes of death worldwide. Despite the significant development of methods of cancer healing during the past decades, chemotherapy still remains the main method for cancer ...

5.

Adjuvant Olaparib for Patients with <i>BRCA1</i> - or <i>BRCA2</i> -Mutated Breast Cancer

Andrew Tutt, Judy E. Garber, Bella Kaufman et al. · 2021 · New England Journal of Medicine · 1.5K citations

Among patients with high-risk, HER2-negative early breast cancer and germline <i>BRCA1</i> or <i>BRCA2</i> pathogenic or likely pathogenic variants, adjuvant olaparib after completion of local trea...

6.

DNA Damage Sensing by the ATM and ATR Kinases

Alexandre Maréchal, Lili Zou · 2013 · Cold Spring Harbor Perspectives in Biology · 1.4K citations

In eukaryotic cells, maintenance of genomic stability relies on the coordinated action of a network of cellular processes, including DNA replication, DNA repair, cell-cycle progression, and others....

7.

Regulation of DNA double-strand break repair pathway choice

Meena Shrivastav, Leyma P. De Haro, Jac A. Nickoloff · 2007 · Cell Research · 1.3K citations

Reading Guide

Foundational Papers

Start with Li and Heyer (2008) for core HRR mechanisms in repair/tolerance, then Shrivastav et al. (2007) for pathway choice regulation, and Abraham (2001) for ATM/ATR signaling context.

Recent Advances

Study Tutt et al. (2021) for adjuvant olaparib in breast cancer, Golan et al. (2019) for pancreatic applications, and Huang and Zhou (2020) for radiotherapy sensitization via DDR targets.

Core Methods

Core techniques: RAD51 foci assays for HR activity, PARP inhibitor sensitivity screens (Fong et al., 2009), ATM/ATR kinase inhibition, and protein modification dynamics tracking (Polo and Jackson, 2011).

How PapersFlow Helps You Research Homologous Recombination Repair

Discover & Search

Research Agent uses citationGraph on Fong et al. (2009) to map 3582-cited PARP inhibitor trials to HRR literature, then findSimilarPapers uncovers BRCA-related mechanisms like Li and Heyer (2008). exaSearch queries 'RAD51 strand invasion BRCA Fanconi' for 250M+ OpenAlex papers.

Analyze & Verify

Analysis Agent applies readPaperContent to Shrivastav et al. (2007), then verifyResponse with CoVe cross-checks pathway choice claims against Abraham (2001). runPythonAnalysis simulates HRR efficiency via NumPy models of strand invasion kinetics; GRADE scores evidence strength for clinical translation.

Synthesize & Write

Synthesis Agent detects gaps in olaparib resistance from Golan et al. (2019) and Bukowski et al. (2020), flags DDR contradictions. Writing Agent uses latexEditText for HRR pathway diagrams, latexSyncCitations integrates 10+ references, latexCompile generates polished reviews; exportMermaid visualizes ATM/ATR signaling cascades.

Use Cases

"Model HRR efficiency in BRCA-deficient cells with survival curves"

Research Agent → searchPapers 'HRR BRCA kinetics' → Analysis Agent → runPythonAnalysis (pandas/matplotlib fits Kaplan-Meier from Fong 2009 data) → survival plot output with statistical p-values.

"Draft LaTeX review on PARP inhibitors in HRR-defective cancers"

Synthesis Agent → gap detection across Tutt 2021/Golan 2019 → Writing Agent → latexEditText (structure sections) → latexSyncCitations (20 refs) → latexCompile → camera-ready PDF with figures.

"Find code for RAD51 simulation in HRR papers"

Research Agent → searchPapers 'RAD51 simulation code' → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → executable HRR model repo with strand invasion scripts.

Automated Workflows

Deep Research workflow scans 50+ HRR papers via searchPapers → citationGraph → structured report on BRCA/PARP synthetic lethality (Fong 2009 baseline). DeepScan's 7-step chain analyzes Polo and Jackson (2011) DDR dynamics with CoVe checkpoints and GRADE scoring. Theorizer generates hypotheses on HRR-ATR crosstalk from Abraham (2001) and Maréchal (2013).

Frequently Asked Questions

What defines homologous recombination repair?

HRR is error-free repair of double-strand breaks using sister chromatid templates via RAD51 strand invasion (Li and Heyer, 2008).

What are key methods in HRR research?

Methods include DR-GFP assays for recombination efficiency and comet assays for break repair; ATM/ATR inhibition studies regulate pathway choice (Shrivastav et al., 2007).

What are landmark HRR papers?

Fong et al. (2009, 3582 citations) showed PARP inhibition in BRCA tumors; Li and Heyer (2008, 1166 citations) detailed HR mechanisms.

What are open problems in HRR?

Challenges include overcoming PARP inhibitor resistance and precise pathway choice control; multidrug resistance links HR defects to chemotherapy failure (Bukowski et al., 2020).

Research DNA Repair Mechanisms with AI

PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:

Start Researching Homologous Recombination Repair with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.